Author:
Xia Xueting,Yang Zongxin,Lu Qisi,Liu Zhenyun,Wang Lei,Du Jinwen,Li Yuhua,Yang Dong-Hua,Wu Shaojie
Publisher
Springer Science and Business Media LLC
Reference225 articles.
1. Batlevi CL, Matsuki E, Brentjens RJ, Younes A. Novel immunotherapies in lymphoid malignancies. Nature reviews. Clin Oncol. 2016;13(1):25–40.
2. Montironi C, Muñoz-Pinedo C, Eldering E. Hematopoietic versus solid cancers and T cell dysfunction: looking for similarities and distinctions. Cancers (Basel). 2021;13(2):284.
3. Frey NV, Porter DL. CAR T-cells merge into the fast lane of cancer care. Am J Hematol. 2016;91(1):146–50.
4. Jena B, Moyes JS, Huls H, Cooper LJN. Driving CAR-Based T-Cell therapy to Success. Curr Hematol Malig Rep. 2014;9(1):50–6.
5. Zhang Z, Wang T, Wang X, Zhang Y, Song S, Ma C. Improving the ability of CAR-T cells to hit solid tumors: challenges and strategies. Pharmacol Res. 2022;175:106036.